摘要
虽然越来越多的冠状动脉慢性闭塞病变正在采用经皮冠状动脉介入治疗,但其临床疗效是否能够与冠状动脉旁路移植术相媲美,目前尚不能妄下结论。经皮冠状动脉介入治疗和冠状动脉旁路移植术在冠状动脉慢性闭塞病变的治疗中各有其最佳适应证,相互之间是不可替代、但可以互补的。而且联合治疗、杂交技术和微创治疗是其未来发展方向。
In the treatment of Chronic Coronary Total Occlusions , more and more percutaneous coronary intervention are being used now. But there is no conclusion about whether the clinical effects of percutaneous coronary intervention is as good as coronary artery bypass grafting. We think percutaneous coronary intervention and coronary artery bypass grafting each has its the best indication, both cannot substitute for one another,but can be complement mutually. And the Combined-treatment,Hybrid and minimally invasive treatment will be developed in the future.
出处
《医学与哲学（B）》
2008年第1期12-14,共3页
Medicine & Philosophy(B)
关键词
冠状动脉慢性闭塞病变
经皮冠状动脉介入治疗
冠状动脉旁路移植术
治疗决策
Chronic Coronary Total Occlusion, percutaneous coronary intervention, coronary artery bypass grafting,treatmental decision-making
